BC
Boxer Capital Portfolio holdings
AUM
$2.04B
1-Year Return
108.35%
This Quarter Return
+38.03%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$439M
AUM Growth
+$38.9M
(+9.7%)
Cap. Flow
-$33.8M
Cap. Flow
% of AUM
-7.7%
Top 10 Holdings %
Top 10 Hldgs %
79.78%
Holding
32
New
6
Increased
4
Reduced
9
Closed
2
Top Buys
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$7.01M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$6.22M |
| 3 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$4.77M |
| 4 |
CBAY
Cymabay Therapeutics
CBAY
|
$4.74M |
| 5 |
Kura Oncology
KURA
|
$4.66M |
Top Sells
| 1 |
Esperion Therapeutics
ESPR
|
$25.1M |
| 2 |
Incyte
INCY
|
$12.6M |
| 3 |
MDCO
Medicines Co
MDCO
|
$11.7M |
| 4 |
PTC Therapeutics
PTCT
|
$9M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$6.47M |
Sector Composition
| 1 | Healthcare | 91.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EIGR
26
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $1.52M | 0.35% |
4,611
| – | – |
|
27
Syndax Pharmaceuticals
SNDX
$1.47B
| $1.17M | 0.27% |
100,000
-134,220
| -57% | -$1.57M |
|
|
NBRV
28
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $710K | 0.16% |
347
-360
| -51% | -$737K |
|
|
ONTXW
29
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
| $528K | 0.12% |
308,793
+67,149
| +28% | +$115K |
|
30
Traws Pharma
TRAW
$12.6M
| $92K | 0.02% |
43
-11
| -20% | -$23.5K |
|
|
31
Incyte
INCY
$16.9B
| – | – |
-100,000
| Closed | -$12.6M |
|
|
SGEN
32
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-125,000
| Closed | -$6.47M |
|